Lina Badimon


Co-Founder and Chief Scientific Officer (CSO)

Director of the ICCC Program and CSIC-Professor, at the IR-Hospital de la Santa Creu i Sant Pau-Universidad Autónoma de Barcelona, Instituto de Investigaciones Biomédicas IIB-SPau; “Lecturer Adjunt Associate Professor” of Medicine – Cardiology – at Mount Sinai School of Medicine, New York (USA), Director of Catalana Occidente Chair -UAB, Director of “UNESCO Chair in Biomedical Sciences Training and Research” and Vicepresident of Scientific Affairs of the “European Society of Cardiology” (ESC).

Her research interest is centred on cardiovascular and cardiometabolic disease, atherosclerosis, thrombosis and ischemic diseases. She has published over 660 articles in highly rated scientific journals and her work has been highly cited in the scientific literature (H-index 88). She has written more than 240 review articles/book chapters. She is co-author of 9 patents. Her previous professional assignments include: “Postdoctoral Fellow” (1981-1983) Division of Cardiovascular Diseases at the Mayo Clinic, Rochester, MN, USA; Director of Research at the Division of Cardiology in the Mount Sinai Medical Center in New York (1983-1991), “Assistant Professor of Medicine” (1983-1987) and “Associate Professor of Medicine” (1988-1991) in Mount Sinai School of Medicine, NY; “Lecturer in Medicine” at Harvard Medical School and “Consultant” at the Cardiac Unit of the Massachusetts General Hospital de Boston (1992-1994).

Her scientific positions of trust include: Vice-President of the Sociedad Española de Cardiología (2014-2016); Chair of the Council on Basic Cardiovascular Science (2014-2016), Past-Chair of the Working Group on Coronary Pathophysiology and Microcirculation (2014-2016) and Past-Chair of the Working Group on Thrombosis (2002-2004) of the “European Society of Cardiology”; President of the European Society for Clinical Investigation (2000-2002); President of the Sociedad Española de Arteriosclerosis (1996-2000). During her career she has received several awards and honours such as: Fellow of the “Cardiovascular Science Council” and of the “Atherosclerosis, Thrombosis and Vascular Biology Council” of the American Heart Association; Fellow of the European Society of Cardiology; Distinguished Fellow of the International Atherosclerosis Society; Honorary Member of the Romanian Society of Hypertension and of the Hungarian Society of Cardiology. Rey Jaime I Award-2014 on Clinical Research. Doctor Honoris Causa by the Carol Davila University of Medicine and Pharmacy (Bucarest, Romania).